Cannabis Science Overview – Plant Tissue Cultures and Dosing

Cannabis Science Overview – Plant Tissue Cultures and Dosing The passage discusses technical aspects of synthetic cannabinoids, dosing, and patents, without mentioning any high‑profile individuals, agencies, or controversial financial flows. It offers no actionable investigative leads related to powerful actors. Key insights: Mentions patented methods for biosynthetic production of cannabinoids in the US.; Notes FDA approval of dronabinol (Marinol) in 1985.; Describes lack of scientific rigor in dosing guidelines and reliance on self‑titration.